EBPL p.Val53Ala
c.158T>C · VCV4246299
Computational evidence
| Protein change | ||
| AlphaMissense | 0.3731 | ambiguous |
|---|---|---|
| REVEL | 0.8 | moderately pathogenic-leaning |
| SaProt | LLR -10.49 | damaging |
| ⇒ REVEL and SaProt both call this damaging; AlphaMissense makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.8 | GERP 1.5, phastCons 1 |
| Regional constraint | o/e 1.02 | unconstrained · MANE · 28 kb · p 0.82 · regional, not allelic |
| Overall | ||
| CADD | 25.6 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.0728% | 1,375 |
| Remaining individualsnot grpmax-eligible | 0.00575% | 17,386 |
| European (non-Finnish) | 9.32e-05% | 1,072,986 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- EBPL
- Protein
- p.Val53Ala
- Coding
- c.158T>C
- MANE Select
- NM_032565
- Type
- single nucleotide variant
- Location
- chr13:49691267 (GRCh38)
- Gene constraint
- LOEUF 1.412 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 94.06
- Residue 53
- the expera domain
Similar variants
- EBPL p.Ala107Ser Uncertain significance ★ ⚠ same type
- EBPL p.Ala107Thr Uncertain significance ★ ⚠ same type
- EBPL p.Ala11Gly Uncertain significance ★ ⚠ same type
- EBPL p.Ala23Glu Uncertain significance ★ ⚠ same type
- EBPL p.Ala27Thr Uncertain significance ★ ⚠ same type
- EBPL p.Ala38Val Uncertain significance ★ ⚠ same type
- EBPL p.Ala39Val Uncertain significance ★ ⚠ same type
- EBPL p.Ala43Gly Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ebpl-p-val53ala (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown